2-(4-hydroxy-3-methoxybenzylidene)-6-(4-hydroxybenzylidene)cyclohexanone

ID: ALA486870

Chembl Id: CHEMBL486870

PubChem CID: 44562535

Max Phase: Preclinical

Molecular Formula: C21H20O4

Molecular Weight: 336.39

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  COc1cc(/C=C2\CCC/C(=C\c3ccc(O)cc3)C2=O)ccc1O

Standard InChI:  InChI=1S/C21H20O4/c1-25-20-13-15(7-10-19(20)23)12-17-4-2-3-16(21(17)24)11-14-5-8-18(22)9-6-14/h5-13,22-23H,2-4H2,1H3/b16-11+,17-12+

Standard InChI Key:  KKJWBHNEOMWQAP-MAEUFBSDSA-N

Associated Targets(Human)

A549 (127892 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MCF7 (126967 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HepG2 (196354 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
U-937 (7138 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PTGS2 Tclin Cyclooxygenase-2 (13999 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

RAW264.7 (28094 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PTGS1 Cyclooxygenase-1 (5266 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 336.39Molecular Weight (Monoisotopic): 336.1362AlogP: 4.33#Rotatable Bonds: 3
Polar Surface Area: 66.76Molecular Species: NEUTRALHBA: 4HBD: 2
#RO5 Violations: HBA (Lipinski): 4HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: 8.89CX Basic pKa: CX LogP: 4.83CX LogD: 4.82
Aromatic Rings: 2Heavy Atoms: 25QED Weighted: 0.82Np Likeness Score: 0.26

References

1. Qiu X, Liu Z, Shao WY, Liu X, Jing DP, Yu YJ, An LK, Huang SL, Bu XZ, Huang ZS, Gu LQ..  (2008)  Synthesis and evaluation of curcumin analogues as potential thioredoxin reductase inhibitors.,  16  (17): [PMID:18678491] [10.1016/j.bmc.2008.07.054]
2. Dong L, Zheng S, Zhang Y, Jiang X, Wu J, Zhang X, Shan X, Liang D, Ying S, Feng J, Liang G.  (2015)  Design, synthesis, and evaluation of semi-conservative mono-carbonyl analogs of curcumin as anti-inflammatory agents against lipopolysaccharide-induced acute lung injury,  (8): [10.1039/C5MD00113G]
3. Mohd Aluwi MF, Rullah K, Yamin BM, Leong SW, Abdul Bahari MN, Lim SJ, Mohd Faudzi SM, Jalil J, Abas F, Mohd Fauzi N, Ismail NH, Jantan I, Lam KW..  (2016)  Synthesis of unsymmetrical monocarbonyl curcumin analogues with potent inhibition on prostaglandin E2 production in LPS-induced murine and human macrophages cell lines.,  26  (10): [PMID:27040659] [10.1016/j.bmcl.2016.03.092]

Source